The reversibility of cancer: evidence that malignancy in melanoma cells is gamma-linolenic acid deficiency-dependent

Certain metabolic abnormalities are common to all malignant cells, and Horrobin proposed that the underlying cause is the inability of cancer cells to produce prostaglandin El (PGE1).

Saved in:
Bibliographic Details
Published inSouth African medical journal Vol. 62; no. 15; pp. 505 - 509
Main Author Dippenaar, N., Booyens, J., Fabbri, D. & Katzeff, I.E.
Format Journal Article
LanguageEnglish
Published South Africa Health and Medical Publishing Group (HMPG) 02.10.1982
Subjects
Animals
Cattle
Cell Count
Cell Transformation, Neoplastic - metabolism
Cells, Cultured
Cellular physiology
Dose-Response Relationship, Drug
Gamma-linolenic acid deficiency
Linoleic Acids - pharmacology
Malignancy
Melanoma - metabolism
Melanoma cells
Methionine - metabolism
Mice
Neoplasms, Experimental - metabolism
Oncology
Prostaglandin E1
Thymidine - metabolism
Online AccessGet full text

Cover

More Information
Summary:Certain metabolic abnormalities are common to all malignant cells, and Horrobin proposed that the underlying cause is the inability of cancer cells to produce prostaglandin El (PGE1).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0256-9574
2078-5135